Somu Subramaniam - Mar 28, 2025 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Director
Signature
/s/ Austin Rutherford, as Attorney-in-Fact
Stock symbol
VTYX
Transactions as of
Mar 28, 2025
Transactions value $
$0
Form type
4
Date filed
4/1/2025, 04:32 PM
Previous filing
Mar 12, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Other $0 -1.34M -24.88% $0.00 4.03M Mar 28, 2025 See Footnote F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 NSV Investments I, L.P. distributed shares to its limited partners on a pro rata basis, for no consideration.
F2 NSV Partners III, L.P. is the general partner of NSV Investments I, L.P. The reporting person is the majority member and managing member of NSV Partners III GP, LLC, which is the general partner of NSV Partners III, L.P., and may be deemed to have voting and dispositive power over the shares owned by each entity of which NSV Partners III, L.P. is general partner. The reporting person is the majority member and managing member of NSV Partners II, LLC. The reporting person is the majority member and managing member of New Science Ventures, LLC. The reporting person disclaims beneficial ownership over the shares owned by each of the NSV Funds (as defined below), except to the extent of his pecuniary interest therein.
F3 The shares beneficially owned by the reporting person consists of: (i) 1,807,664 shares owned by NSV Investments I, L.P., (ii) 1,381,606 shares owned by NSV Partners III, L.P., (iii) 434,423 shares owned by New Science Ventures, LLC, and (iv) 408,520 shares owned by NSV Partners II, LLC (collectively, the "NSV Funds"). The NSV Funds disclaim beneficial ownership over the shares owned by them, except to the extent of their pecuniary interest therein.